Champions Oncology, Inc.
Index- P/E- EPS (ttm)-0.23 Insider Own16.80% Shs Outstand13.56M Perf Week-1.20%
Market Cap54.08M Forward P/E41.00 EPS next Y0.10 Insider Trans0.56% Shs Float10.19M Perf Month-11.83%
Income-3.10M PEG- EPS next Q-0.12 Inst Own72.20% Short Float / Ratio0.56% / 4.61 Perf Quarter-10.09%
Sales53.70M P/S1.01 EPS this Y55.80% Inst Trans-0.69% Short Interest0.06M Perf Half Y-48.10%
Book/sh0.52 P/B7.88 EPS next Y350.00% ROA-8.80% Target Price9.50 Perf Year-51.65%
Cash/sh0.88 P/C4.66 EPS next 5Y15.00% ROE-36.30% 52W Range3.75 - 9.88 Perf YTD-9.09%
Dividend- P/FCF18.65 EPS past 5Y15.60% ROI6.30% 52W High-58.50% Beta0.91
Dividend %- Quick Ratio1.00 Sales past 5Y26.10% Gross Margin47.10% 52W Low9.33% ATR0.14
Employees230 Current Ratio1.00 Sales Q/Q-3.00% Oper. Margin-5.60% RSI (14)42.31 Volatility2.59% 2.86%
OptionableYes Debt/Eq0.00 EPS Q/Q-428.90% Profit Margin-5.80% Rel Volume0.76 Prev Close4.18
ShortableYes LT Debt/Eq0.00 Earnings- Payout0.00% Avg Volume12.48K Price4.10
Recom2.00 SMA20-4.77% SMA50-4.00% SMA200-37.28% Volume9,481 Change-1.91%
Nov-18-19Initiated The Benchmark Company Speculative Buy
Mar-15-23 03:50PM
Mar-13-23 08:30AM
Dec-16-22 08:48AM
Dec-13-22 04:00PM
Dec-09-22 04:30PM
04:00PM Loading…
Sep-08-22 04:00PM
Sep-06-22 04:00PM
Aug-15-22 08:08AM
Jul-23-22 09:57AM
Jul-21-22 04:00PM
Jul-14-22 04:00PM
Jun-13-22 06:30AM
May-31-22 08:30AM
May-03-22 08:30AM
May-02-22 01:16PM
04:45PM Loading…
Mar-15-22 04:45PM
Mar-11-22 08:30AM
Mar-07-22 01:10PM
Feb-15-22 08:30AM
Jan-20-22 08:30AM
Jan-04-22 08:30AM
Dec-13-21 04:20PM
Dec-06-21 09:20AM
Nov-05-21 08:24AM
Oct-20-21 10:25AM
Sep-13-21 04:00PM
Sep-06-21 03:00PM
Sep-02-21 04:30PM
08:30AM Loading…
Jul-26-21 08:30AM
Jul-22-21 08:00AM
Jul-14-21 08:30AM
Jul-08-21 03:06AM
Jun-15-21 09:00AM
Apr-29-21 03:31AM
Apr-16-21 12:00PM
Mar-16-21 10:52AM
Mar-15-21 02:13AM
Mar-11-21 04:00PM
Mar-05-21 08:30AM
Mar-04-21 12:30PM
Feb-22-21 09:00AM
Jan-29-21 12:24AM
Jan-19-21 09:00AM
Jan-05-21 08:30AM
Dec-15-20 12:22AM
Dec-14-20 04:00PM
Dec-07-20 04:00PM
Nov-16-20 04:40PM
Nov-11-20 09:00AM
Oct-31-20 10:08AM
Sep-16-20 07:27AM
Sep-14-20 04:00PM
Sep-08-20 04:30PM
Jul-30-20 07:21AM
Jul-27-20 04:01PM
Jul-22-20 08:00AM
Jul-15-20 03:55PM
Jun-17-20 09:37AM
May-27-20 07:05AM
Apr-28-20 09:50AM
Apr-27-20 07:20AM
Mar-28-20 09:23AM
Mar-16-20 09:35AM
Mar-12-20 04:17PM
Mar-10-20 08:30AM
Feb-26-20 09:32AM
Feb-18-20 05:44AM
Feb-05-20 09:23AM
Jan-29-20 09:00AM
Jan-17-20 09:34AM
Jan-13-20 06:07AM
Dec-24-19 09:37AM
Dec-16-19 04:00PM
Dec-09-19 08:30AM
Dec-08-19 08:59AM
Dec-04-19 08:36AM
Nov-14-19 08:53AM
Nov-13-19 05:00PM
Nov-12-19 07:27AM
Oct-24-19 09:00AM
Oct-18-19 07:41AM
Oct-03-19 08:49AM
Sep-25-19 12:43PM
Sep-16-19 04:00PM
Sep-13-19 08:39AM
Sep-09-19 08:30AM
Sep-02-19 01:30PM
Aug-26-19 08:37AM
Aug-05-19 08:42AM
Jul-29-19 06:48PM
Jul-26-19 06:58AM
Jul-15-19 04:35PM
Jul-12-19 10:00AM
Jul-02-19 09:35AM
May-31-19 09:37AM
May-30-19 08:30AM
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris RonnieCEOMar 17Buy4.0412,38249,969858,878Mar 21 12:30 PM
ACKERMAN JOELDirectorOct 19Option Exercise3.2116,66753,5011,460,595Oct 20 01:26 PM
TOBIN SCOTT RDirectorOct 12Option Exercise3.2110,00032,10030,000Oct 13 09:00 AM
SIDRANSKY DAVIDDirectorOct 12Option Exercise3.218,33326,749770,605Oct 14 02:27 PM
Breitfeld Philip P.DirectorOct 12Option Exercise3.218,33326,74918,200Oct 14 02:25 PM